Headlines

Report: Champion Petfoods Looks at Possible $2B+ Sale

Champion is backed by Bedford Capital, a private equity firm.

Published

2 years ago

June 21, 2022

PETS+ Staff

Alberta, Canada-based Champion Petfoods is considering a sale, according to a media report.

The price tag could exceed $2 billion, Bloomberg reports, citing unnamed “people with knowledge of the matter.”

The company is in the early phases of considering the possibility, according to the report. Other options are also on the table.

Champion officials would not comment for Bloomberg’s story.

Champion is backed by Bedford Capital, a private equity firm.

Reports of a potential Champion sale have emerged before. In 2018, Nestlé was said to be considering a $2 billion purchase of the company.

Read more at Bloomberg

Reduce Your Pet’s Hip & Joint Discomfort with the Most Researched Hyaluronan on the Market

Nearly 60% of dogs and 90% of cats suffer from joint discomfort. Trixsyn joint supplement contains a patented and proven hyaluronic acid molecule for maximum efficacy to promote joint, bone, soft tissue, and cartilage health, keeping your pet feeling comfortable, for longer. Trixsyn is veterinarian recommended, safe and all-natural, and contains research-proven ingredients. Get your paws on the most-researched hyaluronic acid on the market. Learn more at Trixsyn.com.